How engineering can improve cell-based therapy... - CLL Support
How engineering can improve cell-based therapy in chronic lymphocytic leukemia
You need to be a member of this community to see this post.
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Advances in drug‐based therapies in chronic lymphocytic leukemia and future prospects
First published: 08 February 2019 in Advances in Cell and Gene Therapy Journal
Chronic lymphocytic...
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia
"In this study, we demonstrated that ibrutinib treatment enhances the feasibility of generating CAR...
Chronic lymphocytic leukemia treatment algorithm 2022
This 29 November 2022 review article published in the Blood Cancer Journal presents an...
Leukaemia Care Updated Patient Information - Richter's Syndrome in Chronic Lymphocytic Leukaemia
Leukaemia Care is a UK charity so the support information is UK based. However the information...
2025 Update about Chronic Lymphocytic Leukemia, its epidemiology, pathogenesis, diagnosis and therapy
The American Journal of Hematology has published German CLL specialist Michael Hallek's 2025 update...
Related Posts
- Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease
A New Era is Coming up in the Treatment of Chronic Lymphocytic Leukemia
Leukemia-associated macrophages, their role in the CLL Tumor Micro-environment and how they affect progression and therapy response 
Long-Term Ibrutinib Therapy Reverses CD8+ T Cell Exhaustion in B Cell CLL
Trabectedin Targets Leukemic Cells and Restores Immune Cell Function in Models of Chronic Lymphocytic Leukemia
